 | • レポートコード：QYR9N7581 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、ミトコンドリアミオパチーのグローバル市場について調査・分析したレポートで、種類別（カーンズ - セイヤー症候群、リー症候群、ミトコンドリアDNA欠乏症候群、ミトコンドリア脳筋症、ミトコンドリア神経 - 胃腸脳筋症、その他）、用途別（病院、診療所、疾病研究開発機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ミトコンドリアミオパチーの世界市場規模 ・主要企業別市場シェア ・ミトコンドリアミオパチーの世界市場規模：種類別（カーンズ - セイヤー症候群、リー症候群、ミトコンドリアDNA欠乏症候群、ミトコンドリア脳筋症、ミトコンドリア神経 - 胃腸脳筋症、その他） ・ミトコンドリアミオパチーの世界市場規模：用途別（病院、診療所、疾病研究開発機関） ・ミトコンドリアミオパチーのアメリカ市場規模（種類別、用途別） ・ミトコンドリアミオパチーのヨーロッパ市場規模（種類別、用途別） ・ミトコンドリアミオパチーの中国市場規模（種類別、用途別） ・ミトコンドリアミオパチーの日本市場規模（種類別、用途別） ・ミトコンドリアミオパチーの東南アジア市場規模（種類別、用途別） ・ミトコンドリアミオパチーのインド市場規模（種類別、用途別） ・ミトコンドリアミオパチーの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ミトコンドリアミオパチーの世界市場予測（2019年-2025年） ・ミトコンドリアミオパチーの地域別市場予測（2019年-2025年） ... |
Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate “ragged red” muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an increased reactivity for succinate dehydrogenase and a decreased reactivity for cytochrome c oxidase.The identification of patients with possible MM depends upon the investigation of multiple organ dysfunction in the clinical history, examination, and clinical tests. Although there is no disease-modifying therapy for MM, there are numerous points of clinical relevance that can reduce morbidity and improve quality of life for patients with these disorders.
In 2018, the global Mitochondrial Myopathies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Mitochondrial Myopathies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mitochondrial Myopathies development in United States, Europe and China.
The key players covered in this study
Reata Pharmaceuticals
Stealth Biotherapeutics
Raptor Pharmaceutical
Raym Genedx
Neurovive Pharmaceutical
…
Market segment by Type, the product can be split into
Kearns-Sayre Syndrome
Leigh Syndrome
Mitochondrial Dna Depletion Syndrome
Mitochondrial Encephalomyopathy
Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
Myoclonus Epilepsy With Ragged Red Fibers
Neuropathy, Ataxia And Retinitis Pigmentosa
Pearson Syndrome, Progressive External Ophthalmoplegia
Market segment by Application, split into
Hospitals
Clinics
Disease Research and Development Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Mitochondrial Myopathies status, future forecast, growth opportunity, key market and key players.
To present the Mitochondrial Myopathies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Mitochondrial Myopathies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Mitochondrial Myopathies Market Size Growth Rate by Type (2014-2025)
1.4.2 Kearns-Sayre Syndrome
1.4.3 Leigh Syndrome
1.4.4 Mitochondrial Dna Depletion Syndrome
1.4.5 Mitochondrial Encephalomyopathy
1.4.6 Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
1.4.7 Myoclonus Epilepsy With Ragged Red Fibers
1.4.8 Neuropathy, Ataxia And Retinitis Pigmentosa
1.4.9 Pearson Syndrome, Progressive External Ophthalmoplegia
1.5 Market by Application
1.5.1 Global Mitochondrial Myopathies Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Disease Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Mitochondrial Myopathies Market Size
2.2 Mitochondrial Myopathies Growth Trends by Regions
2.2.1 Mitochondrial Myopathies Market Size by Regions (2014-2025)
2.2.2 Mitochondrial Myopathies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Mitochondrial Myopathies Market Size by Manufacturers
3.1.1 Global Mitochondrial Myopathies Revenue by Manufacturers (2014-2019)
3.1.2 Global Mitochondrial Myopathies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Mitochondrial Myopathies Market Concentration Ratio (CR5 and HHI)
3.2 Mitochondrial Myopathies Key Players Head office and Area Served
3.3 Key Players Mitochondrial Myopathies Product/Solution/Service
3.4 Date of Enter into Mitochondrial Myopathies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Mitochondrial Myopathies Market Size by Type (2014-2019)
4.2 Global Mitochondrial Myopathies Market Size by Application (2014-2019)
5 United States
5.1 United States Mitochondrial Myopathies Market Size (2014-2019)
5.2 Mitochondrial Myopathies Key Players in United States
5.3 United States Mitochondrial Myopathies Market Size by Type
5.4 United States Mitochondrial Myopathies Market Size by Application
6 Europe
6.1 Europe Mitochondrial Myopathies Market Size (2014-2019)
6.2 Mitochondrial Myopathies Key Players in Europe
6.3 Europe Mitochondrial Myopathies Market Size by Type
6.4 Europe Mitochondrial Myopathies Market Size by Application
7 China
7.1 China Mitochondrial Myopathies Market Size (2014-2019)
7.2 Mitochondrial Myopathies Key Players in China
7.3 China Mitochondrial Myopathies Market Size by Type
7.4 China Mitochondrial Myopathies Market Size by Application
8 Japan
8.1 Japan Mitochondrial Myopathies Market Size (2014-2019)
8.2 Mitochondrial Myopathies Key Players in Japan
8.3 Japan Mitochondrial Myopathies Market Size by Type
8.4 Japan Mitochondrial Myopathies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Mitochondrial Myopathies Market Size (2014-2019)
9.2 Mitochondrial Myopathies Key Players in Southeast Asia
9.3 Southeast Asia Mitochondrial Myopathies Market Size by Type
9.4 Southeast Asia Mitochondrial Myopathies Market Size by Application
10 India
10.1 India Mitochondrial Myopathies Market Size (2014-2019)
10.2 Mitochondrial Myopathies Key Players in India
10.3 India Mitochondrial Myopathies Market Size by Type
10.4 India Mitochondrial Myopathies Market Size by Application
11 Central & South America
11.1 Central & South America Mitochondrial Myopathies Market Size (2014-2019)
11.2 Mitochondrial Myopathies Key Players in Central & South America
11.3 Central & South America Mitochondrial Myopathies Market Size by Type
11.4 Central & South America Mitochondrial Myopathies Market Size by Application
12 International Players Profiles
12.1 Reata Pharmaceuticals
12.1.1 Reata Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Mitochondrial Myopathies Introduction
12.1.4 Reata Pharmaceuticals Revenue in Mitochondrial Myopathies Business (2014-2019)
12.1.5 Reata Pharmaceuticals Recent Development
12.2 Stealth Biotherapeutics
12.2.1 Stealth Biotherapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Mitochondrial Myopathies Introduction
12.2.4 Stealth Biotherapeutics Revenue in Mitochondrial Myopathies Business (2014-2019)
12.2.5 Stealth Biotherapeutics Recent Development
12.3 Raptor Pharmaceutical
12.3.1 Raptor Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Mitochondrial Myopathies Introduction
12.3.4 Raptor Pharmaceutical Revenue in Mitochondrial Myopathies Business (2014-2019)
12.3.5 Raptor Pharmaceutical Recent Development
12.4 Raym Genedx
12.4.1 Raym Genedx Company Details
12.4.2 Company Description and Business Overview
12.4.3 Mitochondrial Myopathies Introduction
12.4.4 Raym Genedx Revenue in Mitochondrial Myopathies Business (2014-2019)
12.4.5 Raym Genedx Recent Development
12.5 Neurovive Pharmaceutical
12.5.1 Neurovive Pharmaceutical Company Details
12.5.2 Company Description and Business Overview
12.5.3 Mitochondrial Myopathies Introduction
12.5.4 Neurovive Pharmaceutical Revenue in Mitochondrial Myopathies Business (2014-2019)
12.5.5 Neurovive Pharmaceutical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Mitochondrial Myopathies Key Market Segments
Table Key Players Mitochondrial Myopathies Covered
Table Global Mitochondrial Myopathies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Mitochondrial Myopathies Market Size Market Share by Type 2014-2025
Figure Kearns-Sayre Syndrome Figures
Table Key Players of Kearns-Sayre Syndrome
Figure Leigh Syndrome Figures
Table Key Players of Leigh Syndrome
Figure Mitochondrial Dna Depletion Syndrome Figures
Table Key Players of Mitochondrial Dna Depletion Syndrome
Figure Mitochondrial Encephalomyopathy Figures
Table Key Players of Mitochondrial Encephalomyopathy
Figure Mitochondrial Neuro-Gastrointestinal Encephalomyopathy Figures
Table Key Players of Mitochondrial Neuro-Gastrointestinal Encephalomyopathy
Figure Myoclonus Epilepsy With Ragged Red Fibers Figures
Table Key Players of Myoclonus Epilepsy With Ragged Red Fibers
Figure Neuropathy, Ataxia And Retinitis Pigmentosa Figures
Table Key Players of Neuropathy, Ataxia And Retinitis Pigmentosa
Figure Pearson Syndrome, Progressive External Ophthalmoplegia Figures
Table Key Players of Pearson Syndrome, Progressive External Ophthalmoplegia
Table Global Mitochondrial Myopathies Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Disease Research and Development Institutes Case Studies
Figure Mitochondrial Myopathies Report Years Considered
Table Global Mitochondrial Myopathies Market Size 2014-2025 (Million US$)
Figure Global Mitochondrial Myopathies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Mitochondrial Myopathies Market Size by Regions 2014-2025 (Million US$)
Table Global Mitochondrial Myopathies Market Size by Regions 2014-2019 (Million US$)
Table Global Mitochondrial Myopathies Market Share by Regions 2014-2019
Figure Global Mitochondrial Myopathies Market Share by Regions 2014-2019
Figure Global Mitochondrial Myopathies Market Share by Regions 2019
Table Market Top Trends
Table Global Mitochondrial Myopathies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Mitochondrial Myopathies Market Share by Manufacturers (2014-2019)
Figure Global Mitochondrial Myopathies Market Share by Manufacturers in 2018
Table Global Mitochondrial Myopathies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Mitochondrial Myopathies Product/Solution/Service
Table Date of Enter into Mitochondrial Myopathies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Mitochondrial Myopathies Market Size by Type (2014-2019) (Million US$)
Table Global Mitochondrial Myopathies Market Size Share by Type (2014-2019)
Figure Global Mitochondrial Myopathies Market Size Market Share by Type (2014-2019)
Table Global Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table Global Mitochondrial Myopathies Market Size Share by Application (2014-2019)
Figure Global Mitochondrial Myopathies Market Size Market Share by Application (2014-2019)
Figure Global Mitochondrial Myopathies Revenue Market Share by Application in 2018
Figure United States Mitochondrial Myopathies Market Size 2014-2019 (Million US$)
Table United States Key Players Mitochondrial Myopathies Revenue (2018-2019) (Million US$)
Table United States Key Players Mitochondrial Myopathies Market Share (2018-2019)
Table United States Mitochondrial Myopathies Market Size by Type (2014-2019) (Million US$)
Table United States Mitochondrial Myopathies Market Share by Type (2014-2019)
Table United States Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table United States Mitochondrial Myopathies Market Share by Application (2014-2019)
Figure Europe Mitochondrial Myopathies Market Size 2014-2019 (Million US$)
Table Europe Key Players Mitochondrial Myopathies Revenue (2018-2019) (Million US$)
Table Europe Key Players Mitochondrial Myopathies Market Share (2018-2019)
Table Europe Mitochondrial Myopathies Market Size by Type (2014-2019) (Million US$)
Table Europe Mitochondrial Myopathies Market Share by Type (2014-2019)
Table Europe Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table Europe Mitochondrial Myopathies Market Share by Application (2014-2019)
Figure China Mitochondrial Myopathies Market Size 2014-2019 (Million US$)
Table China Key Players Mitochondrial Myopathies Revenue (2018-2019) (Million US$)
Table China Key Players Mitochondrial Myopathies Market Share (2018-2019)
Table China Mitochondrial Myopathies Market Size by Type (2014-20189) (Million US$)
Table China Mitochondrial Myopathies Market Share by Type (2014-2019)
Table China Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table China Mitochondrial Myopathies Market Share by Application (2014-2019)
Figure Japan Mitochondrial Myopathies Market Size 2014-2019 (Million US$)
Table Japan Key Players Mitochondrial Myopathies Revenue (2018-2019) (Million US$)
Table Japan Key Players Mitochondrial Myopathies Market Share (2018-2019)
Table Japan Mitochondrial Myopathies Market Size by Type (2014-2019) (Million US$)
Table Japan Mitochondrial Myopathies Market Share by Type (2014-2019)
Table Japan Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table Japan Mitochondrial Myopathies Market Share by Application (2014-2019)
Figure Southeast Asia Mitochondrial Myopathies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Mitochondrial Myopathies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Mitochondrial Myopathies Market Share (2018-2019)
Table Southeast Asia Mitochondrial Myopathies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Mitochondrial Myopathies Market Share by Type (2014-2019)
Table Southeast Asia Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Mitochondrial Myopathies Market Share by Application (2014-2019)
Figure India Mitochondrial Myopathies Market Size 2014-2019 (Million US$)
Table India Key Players Mitochondrial Myopathies Revenue (2018-2019) (Million US$)
Table India Key Players Mitochondrial Myopathies Market Share (2018-2019)
Table India Mitochondrial Myopathies Market Size by Type (2014-2019) (Million US$)
Table India Mitochondrial Myopathies Market Share by Type (2014-2019)
Table India Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table India Mitochondrial Myopathies Market Share by Application (2014-2019)
Figure Central & South America Mitochondrial Myopathies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Mitochondrial Myopathies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Mitochondrial Myopathies Market Share (2018-2019)
Table Central & South America Mitochondrial Myopathies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Mitochondrial Myopathies Market Share by Type (2014-2019)
Table Central & South America Mitochondrial Myopathies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Mitochondrial Myopathies Market Share by Application (2014-2019)
Table Reata Pharmaceuticals Company Details
Table Reata Pharmaceuticals Revenue in Mitochondrial Myopathies Business (2014-2019) (Million US$)
Figure Reata Pharmaceuticals Revenue Growth Rate in Mitochondrial Myopathies Business (2014-2019)
Table Reata Pharmaceuticals Recent Development
Table Stealth Biotherapeutics Company Details
Table Stealth Biotherapeutics Revenue in Mitochondrial Myopathies Business (2014-2019)(Million US$)
Figure Stealth Biotherapeutics Revenue Growth Rate in Mitochondrial Myopathies Business (2014-2019)
Table Stealth Biotherapeutics Recent Development
Table Raptor Pharmaceutical Company Details
Table Raptor Pharmaceutical Revenue in Mitochondrial Myopathies Business (2014-2019)(Million US$)
Figure Raptor Pharmaceutical Revenue Growth Rate in Mitochondrial Myopathies Business (2014-2019)
Table Raptor Pharmaceutical Recent Development
Table Raym Genedx Company Details
Table Raym Genedx Revenue in Mitochondrial Myopathies Business (2014-2019)(Million US$)
Figure Raym Genedx Revenue Growth Rate in Mitochondrial Myopathies Business (2014-2019)
Table Raym Genedx Recent Development
Table Neurovive Pharmaceutical Company Details
Table Neurovive Pharmaceutical Revenue in Mitochondrial Myopathies Business (2014-2019)(Million US$)
Figure Neurovive Pharmaceutical Revenue Growth Rate in Mitochondrial Myopathies Business (2014-2019)
Table Neurovive Pharmaceutical Recent Development
Table Global Mitochondrial Myopathies Market Size by Regions (Million US$) 2019-2025
Figure Global Mitochondrial Myopathies Market Size Share by Regions (2019-2025)
Figure Global Mitochondrial Myopathies Market Size Share by Regions in 2025
Figure United States Mitochondrial Myopathies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Mitochondrial Myopathies Market Size Forecast (2019-2025)(Million USD)
Figure China Mitochondrial Myopathies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Mitochondrial Myopathies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Mitochondrial Myopathies Market Size Forecast (2019-2025)(Million USD)
Figure India Mitochondrial Myopathies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Mitochondrial Myopathies Market Size Forecast (2019-2025)(Million USD)
Table Global Mitochondrial Myopathies Market Size by Product (2019-2025) (Million US$)
Figure Global Mitochondrial Myopathies Market Size by Product (2019-2025)
Figure Global Mitochondrial Myopathies Market Size by Product in 2025
Table Global Mitochondrial Myopathies Market Size by Application (2019-2025) (Million US$)
Figure Global Mitochondrial Myopathies Market Size by Application (2019-2025)
Figure Global Mitochondrial Myopathies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のチトクロームP450 11B2ミトコンドリア市場2019 The global Cytochrome P450 11B2 Mitochondrial market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Cytochrome P450 11B2 Mitochondrial market status and forecast, categorizes the global Cytochrome…- 世界のミトコンドリアミオパチーの診断と治療市場2019 The global Mitochondrial Myopathy Diagnosis & Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Mitochondrial Myopathy Diagnosis & Treatment market status and forecast, categorizes t…
- 世界のセロトニン症候群市場：市場規模・現状・予測 Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death.US accoun…
- 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測 Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant hematological diseases that affects five out of every 100,000 people in U.S. annually. An estimated 60,000 people in U.S. live with MDS, and approximate…
- 世界の周期性発熱症候群市場：市場規模・現状・予測 Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation.The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. In 2018,…